Dow Jones Reprints: This copy is for your personal, non-commerical use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool on any article or visit www.djreprints.com

Barron's Take

 | TUESDAY, MARCH 1, 2011

Lorillard Lights Up

By TERESA RIVAS | MORE ARTICLES BY AUTHOR

An FDA advisory panel's draft report about menthol cigarettes helps make the case for Lorillard shares.

Lorillard, whose Newport brand is the top selling menthol cigarette, saw its stock rise Tuesday after a Food and Drug Administration advisory panel said menthol cigarettes pose no added health risk.

Late Monday, advisors to the Food and Drug Administration posted two chapters of their report on menthol cigarettes. In one chapter, the panel found that there is insufficient evidence to conclude that smokers of menthol cigarettes face any different or greater health danger than those who smoke regular cigarettes. 

However, in another chapter, the panel cautioned that menthol may make cigarettes more addictive; a ...

Copyright 2010 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com

More Barron's Take

Featured Comment

Real-Time Analysis

Get Emails from Barron's

Partner Center
An Advertising Feature